Transanal total mesorectal excision and low anterior resection syndrome.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
19 08 2021
Historique:
received: 07 12 2020
revised: 22 01 2021
accepted: 27 01 2021
pubmed: 11 4 2021
medline: 17 12 2021
entrez: 10 4 2021
Statut: ppublish

Résumé

Bowel dysfunction after rectal cancer surgery is common, with some experiencing low anterior resection syndrome (LARS) is common after rectal cancer surgery. This study examined if transanal total mesorectal excision (TaTME) has a similar risk of LARS and altered quality of life (QoL) as patients who undergo low anterior resection (LAR). Patients who underwent TaTME or traditionally approached total mesorectal excision in a prospective colorectal cancer cohort study (2014-2019) were propensity score matched in a 1 : 1 ratio. LARS and QoL scores were assessed before and after surgery with a primary endpoint of major LARS at 12 months analysed for possible association between factors by logistic regression. Of 61 TaTME and 317 LAR patients eligible, 55 from each group were propensity score matched. Higher LARS scores (30.6 versus 25.4, P = 0.010) and more major LARS (65 versus 42 per cent, P = 0.013; OR 2.64, 95 per cent c.i. 1.22 to 5.71) were reported after TaTME. Additionally, QoL score differences (body image, bowel frequency, and embarrassment) were worse in the TaTME group. TaTME may be associated with more severe bowel dysfunction than traditional approaches to rectal cancer.

Sections du résumé

BACKGROUND
Bowel dysfunction after rectal cancer surgery is common, with some experiencing low anterior resection syndrome (LARS) is common after rectal cancer surgery. This study examined if transanal total mesorectal excision (TaTME) has a similar risk of LARS and altered quality of life (QoL) as patients who undergo low anterior resection (LAR).
METHODS
Patients who underwent TaTME or traditionally approached total mesorectal excision in a prospective colorectal cancer cohort study (2014-2019) were propensity score matched in a 1 : 1 ratio. LARS and QoL scores were assessed before and after surgery with a primary endpoint of major LARS at 12 months analysed for possible association between factors by logistic regression.
RESULTS
Of 61 TaTME and 317 LAR patients eligible, 55 from each group were propensity score matched. Higher LARS scores (30.6 versus 25.4, P = 0.010) and more major LARS (65 versus 42 per cent, P = 0.013; OR 2.64, 95 per cent c.i. 1.22 to 5.71) were reported after TaTME. Additionally, QoL score differences (body image, bowel frequency, and embarrassment) were worse in the TaTME group.
CONCLUSIONS
TaTME may be associated with more severe bowel dysfunction than traditional approaches to rectal cancer.

Identifiants

pubmed: 33837383
pii: 6219385
doi: 10.1093/bjs/znab056
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

991-997

Investigateurs

G L Beets (GL)
E J Th Belt (EJT)
M Berbée (M)
F H Beverdam (FH)
R Blankenburgh (R)
P P L O Coene (PPLO)
J W B de Groot (JWB)
I H J T de Hingh (IHJT)
A I de Vos (AI)
J H W de Wilt (JHW)
J W T Dekker (JWT)
F L G Erdkamp (FLG)
A W Haringhuizen (AW)
H H Helgason (HH)
M P Hendriks (MP)
R Hoekstra (R)
J N M Ijzermans (JNM)
J Jansen (J)
F W H Kloppenberg (FWH)
M Los (M)
M R Meijerink (MR)
L J M Mekenkamp (LJM)
P Nieboer (P)
K C M J Peeters (KCMJ)
N A J B Peters (NAJB)
M B Polée (MB)
E G G Verdaasdonk (EGG)
P Quarles van Ufford-Mannesse (P)
R C Rietbroek (RC)
A H W Schiphorst (AHW)
A Schouten van der Velden (A)
R W M Schrauwen (RWM)
M P S Sie (MPS)
L Simkens (L)
D W Sommeijer (DW)
D J A Sonneveld (DJA)
L E A Spierings (LEA)
H B A C Stockmann (HBAC)
K Talsma (K)
A J Ten Tije (AJ)
F Terheggen (F)
M L R Tjin-A-Ton (MLR)
L B J Valkenburg-van Iersel (LBJ)
H van Cruijsen (H)
A M T van der Velden (AMT)
J M van Dodewaard-de Jong (JM)
A U G van Lent (AUG)
T van Voorthuizen (T)
M Vermaas (M)
W J Vles (WJ)
J F J Vogelaar (JFJ)
D D E Zimmerman (DDE)
H W M U van Grevenstein (HWMU)
G R Vink (GR)

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

J A G van der Heijden (JAG)

Department of Surgical Oncology, Radboud Institute for Health Science (RIHS), Radboud University Medical Centre, Nijmegen, the Netherlands.

S M Qaderi (SM)

Department of Surgical Oncology, Radboud Institute for Health Science (RIHS), Radboud University Medical Centre, Nijmegen, the Netherlands.

R Verhoeven (R)

Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.
Amsterdam UMC, Department of Medical Oncology, Cancer Centre Amsterdam, Amsterdam, the Netherlands.

J A E Custers (JAE)

Department of Medical Psychology, Radboud University Medical Centre, Nijmegen, the Netherlands.

B R Klarenbeek (BR)

Department of Surgical Oncology, Radboud Institute for Health Science (RIHS), Radboud University Medical Centre, Nijmegen, the Netherlands.

A J G Maaskant-Braat (AJG)

Department of Surgical Oncology, Máxima Medical Centre, Veldhoven, the Netherlands.

J H W de Wilt (JHW)

Department of Surgical Oncology, Radboud Institute for Health Science (RIHS), Radboud University Medical Centre, Nijmegen, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH